RBC Capital raised the firm’s price target on Universal Health (UHS) to $231 from $206 and keeps a Sector Perform rating on the shares. The company reported a headline beat and its behavioral volumes showed modest improvement, though remain below the management’s internal targets, the analyst tells investors in a research note. RBC adds it is encouraged by the management’s sizing of the potential impact of the enhanced exchange subsidies expiration.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UHS:
- Universal Health price target raised to $302 from $280 at UBS
- Universal Health price target raised to $233 from $200 at Morgan Stanley
- Universal Health: Balanced Outlook Amid MSPP Gains and Medicaid Challenges
- Universal Health price target raised to $253 from $227 at Guggenheim
- Universal Health Services Reports Strong Q3 2025 Results